Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Improving biological age gap may help protect long-term brain health

5

Mar 2026

Improving biological age gap may help protect long-term brain health

Improving the gap between your biological age and your chronological age is associated with a lower risk of stroke and improvements in signs of damage in the brain, according to a preliminary study released March 5, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

Single injection may help the heart heal after heart attack

5

Mar 2026

Single injection may help the heart heal after heart attack

For people who have survived a heart attack, the notion of one shot in the arm to help the heart heal, for weeks after, may seem far‑fetched. But thanks to a team of researchers, including a Texas A&M University professor, that's exactly what could happen.

Study reveals compulsive shopping severity is similar across genders but buying choices vary

5

Mar 2026

Study reveals compulsive shopping severity is similar across genders but buying choices vary

Researchers analyzed clinical data from 141 treatment-seeking patients with compulsive buying-shopping disorder to determine whether women and men differ in symptom severity, psychiatric comorbidities, and shopping behaviors. The study found that men and women show similar clinical severity and treatment engagement, but differ mainly in the types of products they compulsively purchase.

Study finds toddlers who eat more ultra-processed foods show slightly higher behavioral symptoms

5

Mar 2026

Study finds toddlers who eat more ultra-processed foods show slightly higher behavioral symptoms

A prospective analysis of 2,077 children in the Canadian CHILD Cohort Study found that higher intake of ultra-processed foods at age three was associated with slightly higher behavioral and emotional symptom scores by age five. Modeling showed that replacing 10% of calories from ultra-processed foods with minimally processed foods was associated with modestly lower symptom scores.

Researchers propose that Parkinson’s disease may start in the gut, not the brain

5

Mar 2026

Researchers propose that Parkinson’s disease may start in the gut, not the brain

A perspective in The Journal of Clinical Investigation argues that environmental exposures may interact with the gut microbiome and intestinal barrier to trigger biological processes linked to Parkinson’s disease. The authors propose that cumulative environmental stressors can erode host resilience, promoting α-synuclein pathology, immune activation, and neurodegeneration.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.